Salarius Pharmaceuticals Market Value
| SLRXDelisted Stock | USD 0.84 0.19 29.23% |
| Symbol | Salarius |
Salarius Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Salarius Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Salarius Pharmaceuticals.
| 12/11/2025 |
| 01/10/2026 |
If you would invest 0.00 in Salarius Pharmaceuticals on December 11, 2025 and sell it all today you would earn a total of 0.00 from holding Salarius Pharmaceuticals or generate 0.0% return on investment in Salarius Pharmaceuticals over 30 days. Salarius Pharmaceuticals is related to or competes with Scisparc, Indaptus Therapeutics, GT Biopharma, Biomotion Sciences, Avenue Therapeutics, Revelation Biosciences, and Lipella Pharmaceuticals. Salarius Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing epigenetic-based cancer tr... More
Salarius Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Salarius Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Salarius Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.18) | |||
| Maximum Drawdown | 61.05 | |||
| Value At Risk | (16.92) | |||
| Potential Upside | 16.0 |
Salarius Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Salarius Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Salarius Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Salarius Pharmaceuticals historical prices to predict the future Salarius Pharmaceuticals' volatility.| Risk Adjusted Performance | (0.12) | |||
| Jensen Alpha | (1.61) | |||
| Total Risk Alpha | (3.06) | |||
| Treynor Ratio | 0.627 |
Salarius Pharmaceuticals Backtested Returns
Salarius Pharmaceuticals owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.17, which indicates the firm had a -0.17 % return per unit of risk over the last 3 months. Salarius Pharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Salarius Pharmaceuticals' Variance of 113.97, coefficient of variation of (578.71), and Risk Adjusted Performance of (0.12) to confirm the risk estimate we provide. The entity has a beta of -2.96, which indicates a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Salarius Pharmaceuticals are expected to decrease by larger amounts. On the other hand, during market turmoil, Salarius Pharmaceuticals is expected to outperform it. At this point, Salarius Pharmaceuticals has a negative expected return of -1.84%. Please make sure to validate Salarius Pharmaceuticals' total risk alpha, kurtosis, as well as the relationship between the Kurtosis and market facilitation index , to decide if Salarius Pharmaceuticals performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.31 |
Poor reverse predictability
Salarius Pharmaceuticals has poor reverse predictability. Overlapping area represents the amount of predictability between Salarius Pharmaceuticals time series from 11th of December 2025 to 26th of December 2025 and 26th of December 2025 to 10th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Salarius Pharmaceuticals price movement. The serial correlation of -0.31 indicates that nearly 31.0% of current Salarius Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.31 | |
| Spearman Rank Test | -0.48 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Salarius Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Salarius Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Salarius Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Salarius Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Salarius Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Salarius Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Salarius Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Salarius Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Salarius Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Salarius Pharmaceuticals Lagged Returns
When evaluating Salarius Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Salarius Pharmaceuticals stock have on its future price. Salarius Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Salarius Pharmaceuticals autocorrelation shows the relationship between Salarius Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Salarius Pharmaceuticals.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Salarius Pharmaceuticals Correlation, Salarius Pharmaceuticals Volatility and Salarius Pharmaceuticals Alpha and Beta module to complement your research on Salarius Pharmaceuticals. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Consideration for investing in Salarius Stock
If you are still planning to invest in Salarius Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Salarius Pharmaceuticals' history and understand the potential risks before investing.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Stocks Directory Find actively traded stocks across global markets | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |